INTRODUCTION
A recent study has demonstrated that the incidence and mortality rate from colorectal cancer (CRC) in Asia are similar to those in Western countries, making it the fourth most common malignancy in this region (World Health Organization 2011) . Increasing evidence suggests that gut microbiota play an important role in the development of CRC (Wu et al., 2013) . Fusobacterium spp., in particular, have been associated with human CRC, as confirmed by metagenomic analyses using whole-genome (Kostic et al., 2012) , transcriptome (Kostic et al., 2012 (Kostic et al., , 2013 and bacterial 16S ribosomal RNA sequencing (Marchesi et al., 2011; Kostic et al., 2012) . Symbiotic Fusobacterium spp. are enriched in CRC tissues relative to adjacent healthy tissues (Castellarin et al., 2012) . For example, a Chinese study that analysed faecal microbial communities in healthy individuals and CRC patients identified a remarkable increase in Fusobacterium nucleatum counts in the CRC cohort compared with the healthy control group (Wu et al., 2013) . Similarly, a North American study found that F. nucleatum was more abundant in stool samples from patients with CRC than in those from healthy subjects (Kostic et al., 2012 (Kostic et al., , 2013 . Additionally, Fusobacterium spp. have been suggested to generate a pro-inflammatory micro-environment that is conducive to the progression of colorectal neoplasia through the recruitment of tumour-infiltrating immune cells (Kostic et al., 2012 (Kostic et al., , 2013 . Thus, F. nucleatum detection might serve as a diagnostic and prognostic determinant for early diagnosis of CRC (Flanagan et al., 2014) .
F. nucleatum is a Gram-negative, invasive obligate anaerobe that has been linked to periodontal, peritonsillar, orofacial, brain, chest, lung, abdominal, blood and obstetrical and gynaecological infections, existing either as part of a mixed infection or as the sole infecting agent (Sklavounos et al., 1986; Brook, 1990; Bauer et al., 2000) . F. nucleatum has strong adhesive qualities and can mediate the adhesion of other bacteria in the oral cavity; it thus plays an important role in plaque formation. The current study found that the F. nucleatum virulence factor Fusobacterium adhesin A (FadA; corresponding fadA GenBank sequence no. DQ012971.1) is involved in the binding to epithelial cells as well as the invasion of host cells as part of a heterogeneous complex, which can result in periodontitis (Han et al., 2005; Xu et al., 2007) . Additionally, FadA binds to E-cadherin in colon cancer cells and activates b-catenin signalling to increase the transcriptional activity of oncogenes, Wnt and pro-inflammatory cytokines, as well as stimulating CRC cell proliferation (Rubinstein et al., 2013; Whitmore & Lamont, 2014) . These findings indicate that FadA is one of the main virulence factors of F. nucleatum and that detection of the fadA gene might indicate whether the bacteria are pathogenic. However, our preliminary results indicated that the fadA sequence is not specific to F. nucleatum; therefore, it would be necessary to evaluate both an F. nucleatum-specific sequence as well as fadA in order to determine the presence and virulence, respectively, of F. nucleatum.
Currently, the main bacterial identification techniques include cultivation, nucleic acid probe hybridization, immunohistochemistry and PCR (Demling et al., 2009 ). Direct cultivation is considered the gold standard among bacterial identification techniques. However, F. nucleatum requires anaerobic growth conditions and does not grow well on conventional culture media (Loomer, 2004) . PCR allows for more precise discrimination and quantification; however, this method is susceptible to inhibitors present in crude biological fluids (de Franchis et al., 1988) , is expensive and requires specialized instrumentation. Thus, these methods are generally not suitable for situations where resources are limited and rapid results are necessary, such as in the case of point-of-care assessments. In contrast, loop-mediated isothermal amplification (LAMP), which was first introduced in 2000, is a simple and cost-effective nucleic acid amplification method that can provide increased sensitivity and specificity for pathogen testing compared to other commonly used methods (Song et al., 2005) . Using Bst DNA polymerase, which is resistant to the aforementioned inhibitors (de Franchis et al., 1988) , the assay can be conducted under isothermal conditions within 60 min, whereas traditional PCR can require up to 3 h (Song et al., 2005) . LAMP uses four to six specific primers that recognize six to eight distinct sequences on the target DNA, thus amplifying the target DNA with high specificity. This method is widely used for clinical diagnosis of epidemic-causing bacteria Ohtsuka et al., 2005) , viruses (Okafuji et al., 2005) and parasites (Chen et al., 2011; Kong et al., 2012) , as well as for foetal sex identification (Hirayama et al., 2006) . LAMP has yet to be used for clinical diagnosis of F. nucleatum. Therefore, in the current study, we identified a gene, nusG, that could be used for the specific detection of F. nucleatum and designed five sets of LAMP primers for that purpose. In addition, we designed three sets of LAMP primers for the detection of fadA, which encodes the F. nucleatum virulence factor, in order to enable early screening of clinical patients with CRC. The specificity of the nusG primers and the sensitivity of the nusG and fadA primers were confirmed, and the LAMP assay was compared to conventional PCR for nusG detection in 57 clinical stool samples.
METHODS
Bacterial strains and samples. In total, 21 bacterial strain samples were used for the LAMP assays (listed in Table 1 ). Clinical samples were obtained from 29 male and 28 female CRC patients at the No. 307 Hospital of PLA. The volunteers were aged 36-78 years and had not used antibiotics for at least 1 month prior to the study. These volunteers shared a relatively homogeneous college campus living environment and diet and had no other obvious diseases. The acquired samples were transported immediately on ice to our laboratory where they were stored in a freezer at À80 C (Haier-Medical). This study was reviewed and approved by the ethics committee of the Academy of Military Medical Sciences (China). All of the volunteers provided written informed consent for participation in this study and the use of their samples.
Cultivation of bacterial strains was performed as follows: sample bacteria were removed from the freezer and recovered in their corresponding culture medium. Fusobacterium spp. were cultured on selective medium (5 % sheep blood with 5 mg ml À1 haemin and 1.0 mg l À1 vitamin K1) with antibiotics (0.001 %, w/v, nalidixic acid and brainheart infusion and Wilkins-Chalgren agar containing 2.5 mg l À1 vancomycin) and incubated for 48 h at 37 C under anaerobic conditions (C31-MGC AnaeroPack TM ; Mitsubishi). The other bacterial strains were cultured in lysogeny broth and incubated for 48 h at 37 C under 5 % CO 2 (DHP-9162; Shanzhi).
DNA extraction. Genomic DNA was extracted from the bacterial strains using the TIANamp Bacteria DNA Kit (Tiangen Biotech) , as measured using Qubit 3.0 (Life Technologies). Stool samples were removed from the freezer and kept at 37 C for 20 min prior to use. DNA was extracted using the QIAamp Fast DNA Stool Mini Kit (cat. no. 51604) according to the manufacturer's instructions, yielding concentrations of approximately 50 ng µl À1 (Supplementary method 2. DNA extraction from stool samples). All DNA samples were stored at À20 C until used as templates in the LAMP and PCR assays.
nusG identification and primer design. The nusG gene was previously identified as a sequence enabling specific detection of F. nucleatum (Castellarin et al., 2012) . BLAST analysis of this sequence (accession no. CP007062.1) in GenBank confirmed that it exists solely in Fusobacterium spp. Five sets of LAMP primers, G 1-5 , were designed for nusG based on this sequence. In addition, three sets of primers, A 1-3 , were designed for fadA based on GenBank accession number DQ012971.1. Primer Explorer V4 software (http:/primerexplorer.jp/lamp) was used to design the outer forward primer (F3), outer backward primer (B3), forward inner primer (FIP), backward inner primer (BIP), forward loop primer (LF) and backward loop primer (LB). Primer sequences are detailed in Table S1 (available in the online Supplementary Material) (primers A 1-3 and G 1-5 used for the determination of optimal LAMP primers). The loop primers (LF and LB) were used to accelerate the amplification reaction. The FIP and BIP primers were linked by a twothymidine spacer (TT). Conventional PCR for nusG was conducted using primer sets E-5 and E-6 as described below; F-5 and F-6 were used for fadA. All primers were synthesized by Sangon Biotech. Detection of LAMP products. Two methods were used to detect LAMP products in this study; one was based on sample turbidity and the other on fluorescence. A Loopamp turbidimeter (LA-320c; Eiken Chemical) was used to monitor real-time amplification by measuring the OD (at 650 nm) every 6 s. During LAMP, changes in turbidity are caused by the presence of the amplification by-product Mg 2 P 2 O 7 , which has a white colour. Alternately, the colour change of the reaction was inspected visually; we were able to observe the change with the naked eye under natural light. For fluorescence detection, an additional 1 µl calcein/Mn 2+ complex (Fluorescent Detection Reagent; Eiken Chemical) was added to the 25 µl LAMP reactions once the reaction mixtures were prepared. The LAMP reaction was regarded as positive if the reaction colour changed from orange to green, whereas if the colour stayed orange, the reaction was considered to be negative. To determine the appropriate reaction temperature, we analysed the efficiency of the reaction at different temperatures ranging from 60 to 67 C at 1 C intervals.
PCR detection. Conventional PCR conditions were used for amplification: 12.5 µl PCR Taq Master Mix (Tiangen Biotech), 9.5 µl doubledistilled water, 1 µl DNA template and 1 µM E-5 and E-6 primers (nusG) or F-5 and F-6 primers (fadA). The sequences of the oligonucleotide primers (E-5, E-6, F-5 and F-6) used to amplify the two genes are detailed in Table 2 . The amplification conditions were as follows: an initial activation step at 94 C for 5 min; 35 amplification cycles of 94 C for 30 s, 56 C for 30 s and 72 C for 30 s; a final extension step at 72 C for 10 min; and holding at 4 C. The PCR products were separated on a 1.5 % agarose gel, stained with GelRed (Biotium) and visualized under a UV trans-illuminator (Bio-Rad).
Clinical sample detection. To investigate the concordance of the results obtained by LAMP and PCR for clinical samples, which might contain factors that interfere with assay accuracy, all 57 samples were simultaneously analysed by both LAMP and traditional PCR as described above.
RESULTS
Determination of optimal LAMP primers and amplification temperature for nusG and fadA detection Real-time turbidity curves (Fig. 1a, b) indicated that the G 3 nusG primer set and the A 1 fadA primer set amplified the target sequences in the shortest time and were thus chosen for subsequent analyses (Table 2) . Reverse primer AGCTTCAGCTTGAAGTCTT As shown in Fig. 2 , the LAMP reaction was optimal between 62 and 65 C; therefore, 64 C was chosen as the most suitable temperature for subsequent reactions.
Specificity of the LAMP reaction
To determine the specificity of nusG detection via LAMP, we used F. nucleatum CGMCC1.2526 as a positive control, distilled water as a no-template control and the DNA from 20 other bacterial strains (Table 1) as test samples. An increase in turbidity was apparent when CGMCC1.2526 DNA was used as the template DNA, whereas no changes in turbidity were apparent in the other tubes (Fig. 3a) . These results are consistent with those obtained using the fluorescent indicator calcein/Mn Table 1 ; L22, no-template control (distilled water).
orange to green during the LAMP assay, whilst the other test samples remained orange, indicative of a negative reaction (Fig. 3b) . Additional replicate LAMP reactions indicated that the nusG primers exhibited good specificity for F. nucleatum DNA.
Sensitivity of the LAMP reaction
To compare the sensitivity of the LAMP and PCR assays, we used serially diluted genomic DNA extracted from F. nucleatum CGMCC1.2526 (22.5-2.25Â10 À3 pg µl À1 ) and distilled water as the no-template control. The detection ; and lane 9, notemplate control.
limit of the LAMP assay for nusG was determined to be 22.5 pg µl À1 by turbidity (Fig. 4a) , and this limit was confirmed using the calcein/Mn 2+ complex (Fig. 4b) ; the PCR detection limit using primers E-5 and E-6 was determined to be 225 pg µl À1 (Fig. 4c) , 10-fold lower than the detection limit using LAMP. Similar results were obtained for fadA; the two LAMP methods exhibited a detection limit of 0.225 pg µl À1 (Fig. 5a, b) for fadA, whilst PCR using primers F-5 and F-6 exhibited a detection limit of 2.25 pg µl À1 (Fig. 5c ).
Detection of nusG and fadA in clinical samples
To determine the correlation of F. nucleatum gene detection in clinical stool samples using LAMP and standard PCR, both assays were performed using samples from 57 CRC patients. Following multiple experiments, nusG was positively detected in 13 of the 57 samples by LAMP and in 8 of the 57 by PCR. It is possible that the F. nucleatum DNA concentration of the other five samples is not within the PCR detection range, resulting in the decreased PCR positivity rate. The presence of the virulence factor, fadA, was examined in the 13 nusG-positive samples. Nine of the 13 samples proved positive for fadA, which demonstrated that the virulence factor could be detected in most F. nucleatum strains.
DISCUSSION
Increasing evidence suggests that certain mucosa-associated bacteria play an important role in the pathogenesis of CRC (Mager, 2006; Rowland, 2009 ). Here, we developed a rapid and efficient method using LAMP for the detection of pathogenic F. nucleatum.
LAMP is generally less time consuming and laborious than traditional methods, as shown by several studies (Yang et al., 2014; Lin et al., 2015; Zhao et al., 2015) . The LAMP method involves the amplification of target genes at a constant temperature, and the reaction duration is usually less than an hour. To the best of our knowledge, this study is the first to report the application of the LAMP assay for the detection of F. nucleatum. Our findings indicate that this method is able to detect nusG from genomic DNA with a detection limit of 22.5 pg µl À1 and that the results were specific for F. nucleatum. LAMP was also able to detect fadA with a detection limit of 0.225 pg µl À1 ; these results are markedly better than those obtained using PCR. The number of positive clinical samples obtained in this study was low compared to the detection rate of F. nucleatum in CRC patients by metagenomic analyses using whole-genome sequencing (Kostic et al., 2012) and bacterial 16S ribosomal RNA gene sequencing (Marchesi et al., 2011) . However, single-gene detection is different from whole-genome sequencing, and thus, the detection rate may differ as well. Interestingly, Yang et al. (2014) determined that 22 of 105 clinical samples were infected with Stenotrophomonas maltophilia using a culturing method and that these positive samples agreed with those detected using the LAMP assay. However, as mentioned previously, F. nucleatum is difficult to culture from stool samples, and thus the culturing method cannot be used to determine the presence of F. nucleatum in samples. PCR could be used as the standard detection method; however, based on our clinical results, LAMP has a higher detection rate for F. nucleatum than PCR. In summary, LAMP is a rapid, simple and convenient method that can be used to screen for the presence of F. nucleatum in normal populations.
Because of its high sensitivity, one obvious limitation of LAMP is the potential for false-positive readings. Strict spatial separation of the reagent preparation area and the testing area and the application of a sealing agent following reaction mixture are therefore necessary. Another drawback of the LAMP method is that primer design is complex; however, once established, the assay is rapid, easy to prepare and highly sensitive and specific and can be conducted under isothermal conditions.
In conclusion, we designed a LAMP-based detection method for the specific, sensitive, rapid and effective detection of pathogenic F. nucleatum. We believe that this assay might be beneficial for the identification of F. nucleatum in hospitals, health units and other point-of-care locations. We anticipate that LAMP will become the new gold standard for the detection of F. nucleatum.
